Stock comparison

ABTvsCVS

Abbott LaboratoriesvsCVS Health Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

ABT

Abbott Laboratories

$91.7

-26.39%

Health Care$161.5BNYSE
CVS

CVS Health Corp

$76.43

-4.09%

Health Care$93.5BNYSE

60-day price, rebased to 100

ABT -15.89% · CVS +2.67%

Round-by-round

ABT 3·CVS 3
EdgeCVS

Valuation upside

-14.50% vs +619.10% to DCF fair value

EdgeABT

Balance-sheet strength

Altman Z 4.61 vs 2.31

EdgeCVS

Fundamental quality

Piotroski 6.00 vs 7.00 (of 9)

EdgeABT

Growth + margins

Rule-of-40 22.40 vs 9.80

EdgeCVS

60-day momentum

-15.89% vs +2.67% price return

EdgeABT

Market-cap liquidity

$161.5B vs $93.5B

Verdict

Across6categories,the two names are evenly matched —3wins each. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onABTorCVS

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.

For informational and educational purposes only. Not financial advice. Learn more